Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiupeng Chen
Institution:
University of Massachusetts Chan Medical School
Observed institutions:
University of Massachusetts Chan Medical School,
Chinese Academy of Sciences,
Institute of Genetics and Developmental Biology,
University of Chinese Academy of Sciences,
State Key Laboratory of Molecular Developmental Biology
ORCID:
0000-0001-5916-3953
Observed ORCID:
0000-0001-5916-3953
OpenAlex ID:
A5078866304
Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor
2024
·
Qing Xie
, Xiupeng Chen
, et al.
·
EMBO Molecular Medicine
·
44
Endogenous ceramide phosphoethanolamine modulates circadian rhythm via neural–glial coupling in Drosophila
2022
·
Xiupeng Chen
, Jie Li
, et al.
·
National Science Review
·
19
PDF
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model
2026
·
Fang Wan
, Jinchen He
, et al.
·
Nature Communications
·
1
PDF
Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance
2026
·
Xiupeng Chen
, Allison M. Keeler
, et al.
·
Molecular Therapy Oncology
“Just right” AAV gene therapy for spinal muscular atrophy
2026
·
Xiupeng Chen
, Jun Xie
·
Molecular Therapy
Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice
2026
·
Xiupeng Chen
, Qing Xie
, et al.
·
Nature Communications
Show more works
View as search
Works count:
6
Citation count:
64
H-index:
2
I10-index:
2
Year
Topic
Type